Developing oncolytic immunotherapies to treat bladder cancer.
| Title |
|---|
| Senior Scientist, Analytical Development Full Time · $140K-$165K Remote, Remote, United States · Remote |
| Senior Clinical Trials Scientist Full Time · $140K-$165K · 7+ YOE United States · Remote |
| Associate Director, Drug Product Full Time · $166K-$195K · 8+ YOE United States · Remote |
| Senior Director, Launch Excellence Full Time · $250K-$265K · 10+ YOE United States · Remote |
| Health Systems Director Full Time · $225K-$235K · 10+ YOE United States · Remote |
| Sr Manager, Corporate Communications & Patient Advocacy Full Time · $157K-$185K · 8+ YOE United States · Remote |
| Regional Business Director (West) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Regional Business Director (Southwest) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Regional Business Director (Great Lakes) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Regional Business Director (Southeast) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Regional Business Director (Mid Atlantic) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Regional Business Director (Northeast) Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Manager, Talent Development Full Time · $123K-$145K · 7+ YOE United States · Remote |
| Manager, Regulatory Affairs (CMC & Clinical) Full Time · $125K-$145K · 5+ YOE United States · Remote |
| Senior Manager, QA - Commercial GMP Full Time · $165K-$185K · 10+ YOE United States · Remote |
| Associate Director, Commercial Data & Business Systems Full Time · $180K-$190K · 8+ YOE United States · Remote |
| Vice President, Analytical Development & Quality Control Full Time · $310K-$335K · 15+ YOE United States · Remote |
| National Strategic Account Executive Full Time · $204K-$240K · 10+ YOE United States · Remote |
| Activities | Pharmaceutical drug developmentBiotechnology researchClinical trial managementOncology treatment discoveryMedical therapy commercialization |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | CG Oncology |
| Employees | 142 |
| Type | Public |
| Tagline | Developing oncolytic immunotherapies to treat bladder cancer. |
| Founded | 2,010 |
| Website | cgoncology.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | CGON |